JNJ
190.6
-0.77%↓
ABT
126.77
+0.33%↑
MDT
93.77
-0.45%↓
VEEV
293.21
+0.68%↑
A
148.21
+0.39%↑
JNJ
190.6
-0.77%↓
ABT
126.77
+0.33%↑
MDT
93.77
-0.45%↓
VEEV
293.21
+0.68%↑
A
148.21
+0.39%↑
JNJ
190.6
-0.77%↓
ABT
126.77
+0.33%↑
MDT
93.77
-0.45%↓
VEEV
293.21
+0.68%↑
A
148.21
+0.39%↑
JNJ
190.6
-0.77%↓
ABT
126.77
+0.33%↑
MDT
93.77
-0.45%↓
VEEV
293.21
+0.68%↑
A
148.21
+0.39%↑
JNJ
190.6
-0.77%↓
ABT
126.77
+0.33%↑
MDT
93.77
-0.45%↓
VEEV
293.21
+0.68%↑
A
148.21
+0.39%↑
24h
Actuel
Min
2.52
Max
2.57
Recommandations | Achat |
|---|---|
Prévisions sur 12 Mois | +477.69% upside |
Prochains Résultats | 12 nov. 2025 |
|---|
Les performances passées ne sont pas un indicateur fiable des résultats futurs.
1 oct. 2025, 15:07 UTC
Fortress Biotech Shares Drop After FDA Letter for CUTX-101 Manufacturing Facility
DJ
Lire
10 mars 2025, 02:12 UTC
Checkpoint Controlling Shareholder Fortress Has Agreed to Vote in Favor of Transaction >524715.BY
DJ
Lire
10 mars 2025, 02:12 UTC
Sun Pharma, Checkpoint Transaction Expected to Complete in 2Q 2025 >524715.BY
DJ
Lire
10 mars 2025, 02:11 UTC
Sun Pharma, Checkpoint, Fortress Biotech Enter Into Royalty Agreement >524715.BY
DJ
Lire
10 mars 2025, 02:11 UTC
Checkpoint Shareholders Entitled to Receive Up to Additional $0.70 if Cosibelimab if Approved in EU Prior to Certain Deadlines >524715.BY
DJ
Lire
10 mars 2025, 02:10 UTC
Checkpoint Shareholders to Receive Upfront Cash Payment of $4.10/Share, Contingent Value Right >524715.BY
DJ
Lire
10 mars 2025, 02:10 UTC
Sun Pharma to Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Lire
10 mars 2025, 02:06 UTC
Sun Pharma To Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Lire
Variation de prix
By TipRanks
Prévisions sur 12 Mois
Moyen 14.5 USD 477.69%
Haut 17 USD
Bas 12 USD
Basé sur 2 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.
By TipRanks
Achat
2 ratings
2
Achat
0
Maintien
0
Vente
Basé sur 2 qui ont noté l'action Microsoft Corp. au cours des 3 derniers mois.
$